[1]
D. A. M. Sharaf Eldeen and A. E. Abdelgawad, “Gemcitabine and vinorelbine: treatment option in recurrent platinum – resistant ovarian cancer”, Eur J Oncol Env Hea, vol. 22, no. 3-4, pp. 131–137, Mar. 2018, Accessed: Feb. 23, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/6086